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Abstract
Objective:  To  explore  the  effect  of  erythromycin  on  hyperoxia-induced  lung  injury.
Methods:  One-day-old  preterm  offspring  Sprague-Dawley  (SD)  rats  were  randomly  divided  into
four  groups:  group  1,  air  +  sodium  chloride;  group  2,  air  +  erythromycin;group  3,  hyperoxia  +
sodium  chloride;  and  group  4,  hyperoxia  +  erythromycin.  At  one,  seven,  and  14  days  of  expo-
sure,  glutathione  (GSH)  and  interleukin-1  beta  (IL-1  beta)  were  detected  by  double-antibody
sandwich enzyme-linked  immunosorbent  assay  (ELISA),  and  bicinchoninic  acid  (BCA)  was  used
to  detect  GSH  protein.  -glutamine-cysteine  synthetase  (-GCS)  mRNA  was  detected  by  reverse
transcription-polymerase  chain  reaction  (RT-PCR).
Results:  Compared  with  group  1,  expressions  of  GSH  and  -GCS  mRNA  in  group  3  were  signiﬁ-
cantly increased  at  one  and  seven  days  of  exposure  (p  <  0.05),  but  expression  of  -GCS  mRNA  was
signiﬁcantly  reduced  at  14  days;  expression  of  IL-1  beta  in  group  3  was  signiﬁcantly  increased
at  seven  days  of  exposure  (p  <  0.05),  and  was  signiﬁcantly  reduced  at  14  days.  Compared  with
group  3,  expressions  of  GSH  and  -GCS  mRNA  in  group  4  were  signiﬁcantly  increased  at  one,
seven,  and  14  days  of  exposure  (p  <  0.05),  but  expressions  of  GSH  showed  a  downward  trend  at
14  days;  expression  of  IL-1  beta  in  group  4  was  signiﬁcantly  reduced  at  one  and  seven  days  of
exposure  (p  <  0.05).
Conclusions:  Changes  in  oxidant-mediated  IL-1  beta  and  GSH  are  involved  in  the  development
of hyperoxia-induced  lung  injury.  Erythromycin  may  up-regulate  the  activity  of  -GCS,  increas-
ing  the  expression  of  GSH,  inhibiting  the  levels  of  oxidant-mediated  IL-1  beta  and  alleviating
hyperoxia-induced  lung  injury  via  an  antioxidant  effect.
©  2014  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
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PALAVRAS-CHAVE
Eritromicina;
Hiperóxia;
Lesão  pulmonar;
Glutationa;
Interleucina-1  beta
Efeitos  da  eritromicina  sobre  a  -glutamil-cisteína-sintetase  e  a  interleucina-1  no
tecido  pulmonar  exposto  à  hiperóxia  de  ratos  recém-nascidos  prematuros
Resumo
Objetivo:  Explorar  o  efeito  da  eritromicina  sobre  lesões  pulmonares  induzidas  por  hiperóxia.
Métodos:  Uma  prole  de  ratos  Sprague-Dawley  (SD)  prematuros  com  um  dia  de  vida  foi  dividida
aleatoriamente em  quatro  grupos:  grupo  1  ar  +  cloreto  de  sódio,  grupo  2  ar  +  eritromicina,
grupo 3  hiperóxia  +  cloreto  de  sódio  e  grupo  4  hiperóxia  +  eritromicina.  Com  um,  sete  e  14
dias  de  exposic¸ão,  foram  detectadas  Glutationa  (GSH)  e  Interleucina-1  beta  (IL-1  beta)  pelo
ensaio  imunossorvente  ligado  à  enzima  (ELISA),  e  o  ácido  bicinconinico  (BCA)  foi  utilizado  para
detectar  a  proteína  GSH.  O  mRNA  da  -glutamil-cisteina-sintetase  (-GCS)  foi  detectado  por
reac¸ão  em  cadeia  da  polimerase  via  transcriptase  reversa  (RT-PCR).
Resultados:  Comparadas  ao  grupo  1,  as  expressões  do  mRNA  da  GSH  e  da  -GCS  no  grupo  3
aumentaram signiﬁcativamente  com  um  e  sete  dias  de  exposic¸ão  (p  <  0,05),  porém  a  expressão
de  mRNA  da  -GCS  diminuiu  signiﬁcativamente  aos  14  dias;  a  expressão  de  IL-1  beta  no  grupo
3  aumentou  signiﬁcativamente  aos  7  dias  de  exposic¸ão  (p  <  0,05)  e  diminuiu  signiﬁcativamente
aos 14  dias.  Comparadas  ao  grupo  3,  as  expressões  do  mRNA  da  GSH  e  da  -GCS  no  grupo
4 aumentaram  signiﬁcativamente  com  um,  sete  e  14  dias  de  exposic¸ão  (p  <  0,05),  porém  as
expressões  de  GSH  mostraram  uma  tendência  de  queda  aos  14  dias;  a  expressão  de  IL-1  beta
no  grupo  4  foi  reduzida  signiﬁcativamente  com  um  e  sete  dias  de  exposic¸ão  (p  <  0,05).
Conclusões: As  variac¸ões  de  IL-1  beta  e  GSH  mediadas  por  oxidantes  estão  envolvidas  no
desenvolvimento de  lesão  pulmonar  induzida  por  hiperóxia.  A  eritromicina  poderá  regular
positivamente  a  atividade  da  -GCS,  aumentando  a  expressão  de  GSH,  inibindo  os  níveis  de
interleucina-1beta  mediada  por  oxidante  e  aliviando  a  lesão  pulmonar  induzida  por  hiperóxia
por  meio  de  um  efeito  antioxidante.
© 2014  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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Adult  Sprague-Dawley  (SD)  rats  (weighing  200-250  g,  and
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ith  the  rapid  development  of  maternal  health  technol-
gy and  perinatology,  the  survival  rate  of  premature  infants
s increasing,  especially  in  very  low  birth  weight  infants
VLBWI).1 However,  the  lungs  of  premature  infants  are  often
mmature and  in  direct  contact  with  oxygen,  and  they  are
ne of  the  most  sensitive  organs  to  oxygen  toxicity.  More-
ver, premature  infants  need  to  receive  various  oxygen
herapies for  a  long  time  after  birth.  Unfortunately,  this
ndoubtedly aggravates  oxidative  stress  in  the  immature
ungs of  premature  infants,  which  may  lead  to  acute  and
hronic lung  injury.2
Hyperoxia-induced  lung  injury  is  a  major  cause  of  chronic
espiratory disease  from  infancy  to  adulthood,  and  has
ecome one  of  the  most  difﬁcult  problems  in  the  neonatal
ntensive care  unit.  However,  its  etiology  and  pathogene-
is are  not  fully  understood.3 Nowadays,  most  researchers
elieve that  immature  lung  tissue  directly  exposed  to
he hyperoxic  environment  results  in  oxidative  stress,
hich has  a  crucial  role  in  the  development  of  hyperoxia-
nduced lung  injury.4,5 Oxidative  stress  can  disturb  the
xidant/antioxidant balance,  and  is  one  of  the  primary
athogenic factors.6 Glutathione  (GSH)  is  an  important
ntracellular antioxidant  and  has  a  key  role  in  maintain-
ng integrity  and  preventing  oxidative  damage  in  alveolar
pithelial cells.7 -glutamine-cysteine  synthetase  (-GCS)
s the  rate-limiting  enzyme  of  GSH  protein  synthesis,  and
egulates intracellular  levels  of  GSH.8 IL-1  beta  is  present
n the  early  phase  of  bronchopulmonary  dysplasia  (BPD)  in
i
E
Gremature  infants,  and  may  have  an  important  role  in  the
evelopment of  BPD.  However,  the  exact  pathogenesis  of
PD remains  unclear,  and  clinically  effective  treatments
emain limited.
The non-antibacterial  effect  of  erythromycin  has  grad-
ally attracted  the  attention  of  several  researchers.9 It
xhibits many  important  physiological  functions,  includ-
ng: effective  antibacterial  activity,  non-speciﬁc  anti-
nﬂammatory effects  in  asthma,  immune  regulation,
nduced chemical  adhesion,  promoted  gastrointestinal
otility, and  an  anti-tumor  effect.10 Erythromycin  effec-
ively treats  many  non-bacterial,  infective  chronic  inﬂam-
atory diseases,  some  of  which  show  imbalanced  redox
eactions.11 However,  it  remains  unclear  how  the  expres-
ion levels  of  GSH,  -GCS,  and  IL-1  beta  are  affected  in
yperoxia-exposed lung  tissue.  In  the  present  study,  the
uthors explored  the  effect  of  erythromycin  on  hyperoxia-
nduced lung  injury  in  premature  rats  and  examined  the
xpression levels  of  GSH,  -GCS,  and  IL-1  beta  in  premature
at pulmonary  tissues.
aterials and methods
xperimental  animal  models12 and  groupingncluding 100  females  and  35  males)  were  provided  by  the
xperimental Animal  Center  of  the  Chinese  Minority  Ethnic
roups Traditional  Medicine  Research  Center  of  the  Central
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pEffects  of  erythromycin  on  -glutamyl  cysteine  synthetase  a
University  for  Nationalities,  Beijing,  China.  The  ﬁrst  day  of
pregnancy was  recorded  when  sperm  was  detected  in  the
vaginal sections  of  female  rats  by  microscopic  examination.
On day  21  of  gestation  (term  =  22  days)  fetuses  were  deliv-
ered by  hysterectomy.  The  one-day-old  preterm  SD  rats  were
randomly divided  into  four  groups  (eight  pups  in  each  group):
group 1  received  air  (21%  O2)  +  sodium  chloride;  group  2,  air
+ erythromycin;  group  3,  hyperoxia  +  sodium  chloride;  and
group 4,  hyperoxia  +  erythromycin.  Rats  in  the  air  groups
were exposed  to  room  air,  whereas  those  in  the  hyperoxia
groups were  exposed  to  O2 concentrations  >  85%  and  CO2 <
0.5%. Temperatures  were  kept  at  25-26 ◦C  and  humidity  at
60-70%, and  the  oxygen  and  CO2 levels  in  the  chamber  were
monitored continuously  with  gas  analyzers.12 The  caudal
vein of  the  preterm  rats  was  injected  with  sodium  chloride
(0.15 mL/kg)  in  the  sodium  chloride  groups,  and  erythromy-
cin (50  mg/kg)  in  the  erythromycin  groups.  At  one,  seven,
and 14  days  of  exposure,  eight  pups  from  each  group  were
anesthetized and  euthanized.  Protein  was  extracted  from
the left  lung,  and  the  right  lung  was  frozen  and  stored  at
--70◦ C  in  a  refrigerator  for  RT-PCR.
The  study  was  approved  by  the  experimental  animal
welfare management  and  ethics  committee  of  Shanghai  Chil-
dren’s Hospital,  Shanghai  Jiao  Tong  University,  Shanghai,
China.
Detection  of  GSH  and  IL-1  beta  in  pulmonary  tissue
homogenates by  ELISA
Lung  tissues  were  collected,  and  total  proteins  were
extracted using  a  protein  extraction  kit.  Protein  concen-
tration was  measured  using  the  Bradford  method  (Bio-Rad
- California,  USA).  GSH  and  IL-1  beta  in  pulmonary  tissue
homogenates were  detected  by  ELISA  kits  obtained  from
Nanjing Jiancheng  Biological  Technology  Co.  Ltd.,  Nanjing,
China and  Wuhan  Huamei  Cusabio  Biological  Technology  Co.
Ltd.,  Wuhan,  China,  respectively.
All  reagents  were  allowed  to  reach  room  temperature.
The required  number  of  strips  were  arranged  and  labeled.
100-L of  reagents  were  added  to  wells  of  polystyrene
ELISA plates,  and  the  wells  were  thoroughly  washed  with
phosphate buffered  saline  (PBS)  containing  0.1%  Tween-20
(PBS-Tween) (Bio-Rad  Laboratories,  CA,  EUA)  after  each
incubation step.  All  reagents  were  prepared,  including  work-
ing standards  and  samples.  100  uL  of  standards,  controls,  or
samples were  added  to  the  wells  and  were  incubated  for
two hours  at  37◦C.  After  the  wells  were  washed,  100  uL  of
goat anti-mouse  GSH  (or  IL-1  beta)  polyclonal  antibody  was
added to  each  well  (incubation,  37 ◦C,  30  min).  After  exten-
sive wash,  100  uL  of  rabbit  anti-goat  immunoglobulin  G  (IgG)
was added  to  each  well  for  one  hour  at  37◦ C.  After  substrate
solution and  stop  solution  incubation,  the  optical  density  of
each well  was  read  within  30  minutes,  using  a  microplate
reader set  to  450  nm.
Detecting  of  GSH  protein  concentrations  in
pulmonary tissue  homogenates  through
bicinchoninic acid  (BCA)
Following  the  standard  protocol  for  the  Micro  BCA  Pro-
tein Assay  Kit  (Beijing  Baitaike  Biological  Technology  Co.,
f
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eijing,  China),  the  working  solution  consisted  of  1  vol-
me reagent  C  mixed  with  25  volumes  of  reagent  B;  then,
6 volumes  of  reagent  A  were  added  to  the  C/B  mix-
ure. The  pH  value  of  the  working  solution  was  11.16
 0.06,  measured  with  an  Orion  310  (Thermo  Scien-
iﬁc, MA,  EUA)  pH  meter.  Completely  dissolved  protein
tandard (5  mg/ml),  10  L  diluted  to  100  L,  so  that  the
nal concentration  was  0.5  mg/ml,  would  be  diluted  stan-
ards according  to  0,1,2,4,8,12,16,20  L  respectively  to
6-well plate,  and  ultra  pure  water  would  all  standard  up
o 20  L,  and  10  L samples  to  96-well  plate,  plus  ultra
ure water  release  liquid  to  20  L,  the  hole  added  with
00 L BCA  the  working  solution,  gently  tap  the  plate  to
nsure thorough  mixing  with  a sample  adding  gun,  cooling
he samples  to  room  temperature  from  37 ◦C  for  30-60  min.
ach measurement  was  performed  in  duplicate.  All  the
bsorbances were  corrected  by  the  corresponding  blank
eplicate. The  absorbance  of  the  blank  solution  was  0.048
 0.006.  Absorbance  at  562  nm  was  measured  by  spec-
rophotometer using  glass  cuvettes  with  optical  path  length
f 0.1  cm.
xpression  of  -GCS  mRNA  detected  by  RT-PCR
otal  RNA  was  extracted  using  the  RNAgent  Total  RNA  Iso-
ation System  (Promega  Corporation,  WI,  EUA)  according
o the  manufacturer’s  instructions.  The  purity  and  yield
f total  RNA  were  determined  spectrophotometrically  by
easuring the  absorbance  of  an  aliquot  at  260  nm  and
80 nm.  RNA  (4  g)  was  reverse-transcribed  into  50  L  of
omplementary DNA  (cDNA)  using  the  M-MLV  Reverse  Trans-
riptase system  (Jingmei  Biotech  Ltd,  Shenzhen,  China).
he primer  sequences  were  designed  by  Shanghai  Biology
ngineering Co.,  China,  in  accordance  with  the  literature:
-GCS, forward:  5′-TTGGCAGCCTT  CCTGATTTC-3′,  reverse:
′-AACTTCTCCACAACCCTCTG-3′,  product  size  78  bp;  -
ctin, forward:  5′-AAC  GCAGCTCAGTAACAGTC-3′,  reverse:
′-ATCCGT  AAA  AGCCTCTATGC  -3′,  product  size  280  bp.  -
CS and  -actin  PCR  reaction  mixtures  were  subjected  to
ncubation for  5  min  at  94 ◦C,  followed  by  35  cycles  of
4◦ C  for  45  s,  50◦ C  for  one  min,  and  72◦ C  for  30  s.
 ﬁnal  extension  was  carried  out  at  72◦ C  for  ten  min.
CR products  were  separated  by  electrophoresis  on  2%
garose gels,  stained  with  ethidium  bromide  (0.5  g/mL),
nd observed  using  a  UV  transilluminator  and  evaluated
sing a  GDS-8000  gel  image  system  (UVP  Co.,  Cambridge,
nited Kingdom)  by  comparing  the  intensity  of  target
roduct bands  with  that  of  -actin  used  as  the  internal
tandard.
tatistical  Analysis
ata  were  analyzed  using  the  statistical  software  package
PSS, version  16.0  (IBM,  Armonk,  NY,  USA).  All  data  were
resented as  means  ±  standard  deviation.  Statistical  dif-
erences between  the  groups  were  tested  by  ANOVA,  and
ata between  two  groups  were  analyzed  using  the  q-test.
 p-value  less  than  0.05  was  considered  to  be  statistically
igniﬁcant.
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Figure  1  Expression  of  GSH  protein  in  premature  rat  lungs  detected  by  ELISA.
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bSH, glutathione;  ELISA,  enzyme-linked  immunosorbent  assay.
p  <  0.05,  compared  with  group  1.
p  <  0.05,  compared  with  group  3.
esults
ffect  of  erythromycin  on  GSH  in
yperoxia-exposed lung  tissue
ompared  with  group  1,  expression  of  GSH  in  group  3  was
igniﬁcantly increased  (p  <  0.05)  at  one  and  seven  days  of
xposure, but  showed  no  signiﬁcant  reduction  (p  >  0.05)  at
4 days.  Compared  with  group  3,  expression  of  GSH  in  group
 was  signiﬁcantly  increased  at  one,  seven,  and  14  days  of
xposure (p  <  0.05);  the  general  tendency  decreased  after
4 days  (Figs.  1  and  2).
ffect  of  erythromycin  on  IL-1  beta  in
yperoxia-exposed lung  tissue
ompared  with  group  1,  expression  of  IL-1  beta  in  group  3
as signiﬁcantly  increased  (p  <  0.05)  at  seven  days  of  expo-
ure; its  expression  was  signiﬁcantly  reduced  (p  <  0.05)  at
4 days  of  exposure.  Compared  with  group  3,  expression  of
L-1 beta  in  group  4  became  signiﬁcantly  reduced  at  one  and
even days  of  exposure  (p  <  0.05)  (Fig.  3).
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igure  2  Expression  of  GSH  protein  in  premature  rat  lungs  detect
SH, glutathione;  BCA,  bicinchoninic  acid.
p  <  0.05,  compared  with  group  1.
p  <  0.05,  compared  with  group  3.ffect  of  erythromycin  on  -GCS  in
yperoxia-exposed lung  tissue
ompared  with  group  1,  expression  of  -GCS  mRNA  in  group
 was  signiﬁcantly  increased  (p  < 0.05)  at  one  and  seven
ays of  exposure;  its  expression  was  signiﬁcantly  reduced
p <  0.05)  at  14  days  of  exposure.  Compared  with  group
, expression  of  -GCS  mRNA  in  group  4  was  signiﬁcantly
ncreased at  one,  seven,  and  14  days  of  exposure  (p  <  0.05)
Fig. 4).  Erythromycin  intervention  up-regulated  the  activity
f -GCS  mRNA  particularly  in  the  hyperoxia-exposed  lung
issues.
iscussion
ased  on  the  histological  features,  rat  fetal  lung  develop-
ent can  be  divided  into  four  periods:  the  embryonic  period
zero to  13  days),  gland  period  (14  to  18  days),  canalicular
tage (19  to  20  days),  and  saccular  period  (21  to  22  days).
he saccular  period  during  the  development  of  human  lung
orresponds to  28  to  34  weeks  of  gestational  age,  the  age
f birth  of  most  preterm  neonates.  The  postnatal  rat  lung
evelopment is  divided  into  three  periods:  the  expansion
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Figure  3  Expression  of  IL-1  beta  protein  in  premature  rat  lungs  detected  by  ELISA.
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period  (one  to  four  days  after  birth),  alveolar  period  (four
to 13  days  after  birth),  and  balanced  growth  period  (14  to
21 days  after  birth).  Thus,  the  different  time  points  respec-
tively represent  the  different  stages  of  lung  development  in
preterm infants  after  birth.
The  pathogenesis  and  prevention  of  BPD  in  preterm
infants has  made  signiﬁcant  breakthroughs  recently;  how-
ever, the  exact  pathogenesis  of  BPD  remains  unclear,
and effective  treatment  is  still  signiﬁcantly  restricted.13
Macrolide  antibiotics  (MAs)  contain  the  12-22  carbon
chemical structure  and  belong  to  the  lactone  ring  car-
bon antibiotics.  Erythromycin  A  can  inhibit  the  secretion
of pro-inﬂammatory  cytokines  such  as  tumor  necrosis
factor- and  IL-1beta.14 Moreover,  it  is  an  extremely  broad-
spectrum antibiotic,  and  has  antibacterial  activity  against
Gram-positive bacteria  and  some  Gram-negative  bacteria,
anaerobic bacteria,  Legionella,  Chlamydia,  Mycoplasma,
and Rickettsia.15 Long-term  clinical  practice  and  in-depth
pharmacological studies  have  showed  that  MAs  not  only
have antibacterial  effects,  but  also  possess  non-speciﬁc
anti-inﬂammatory,  anti-allergic,  and  immune  regulation
properties.16 The  main  role  of  antibiotics  in  some  chronic
pulmonary inﬂammatory  diseases  may  be  related  to  inhib-
iting the  oxidative  burst  of  neutrophils  and  the  release  of
m
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Figure  4  Expression  of  -GCS  mRNA  in  premature  rat  lungs  detect
-GCS, -glutamine  cysteine  synthetase;  RT-PCR,  reverse  transcripti
ap  <  0.05,  compared  with  group  1.
bp  <  0.05,  compared  with  group  3.assay.
nﬂammatory  mediators.  In  addition,  MAs  are  effective  in
reventing and  treating  some  respiratory  diseases,  includ-
ng asthma,  pulmonary  ﬁbrosis,  diffuse  panbronchiolitis,  and
ome non-infectious  inﬂammatory  diseases,  such  as  blood
iseases, skin  diseases,  and  cancer;  these  functions  have
othing to  do  with  the  antibacterial  activities.17
Glutathione  is  a  tripeptide-containing  sulfonium
ompound, composed  of  glycine,  glutamic  acid,  and  cys-
ine. -GCS  is  the  rate-limiting  enzyme  of  GSH  synthesis
hat regulates  intracellular  GSH  levels.18 GSH  is  activated
y the  in  vivo  oxidation/reduction  system,  and  provides  the
eductant for  cystine,  inhibiting  the  body’s  production  of
arious substances  in  the  process  of  oxidation  of  reactive
xygen species  (ROS),  inactivating  activity  of  membrane
eroxidase and  inhibiting  ROS,  thus  reducing  ROS.  Most
esearchers have  recognized  that  ROS  caused  by  oxida-
ive stress  has  an  important  role  in  the  development  of
yperoxia-induced lung  injury.19 Several  studies  with  in  vivo
nd in  vitro  experiments  have  demonstrated  that,  as  an
mportant antioxidant,  GSH  played  an  important  role  in
aintaining the  airway  epithelial  cell  integrity  and  resisting
ung injury  and  inﬂammation.20
In  the  present  study,  compared  with  the  air  +  sodium  chlo-
ide group,  GSH  expression  in  lung  tissues  of  premature  rats
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as  signiﬁcantly  enhanced  after  erythromycin  intervention
n day  one,  seven,  and  14  in  the  erythromycin  +  sodium
hloride group  (p  <  0.05);  its  expression  was  signiﬁcantly
nhanced on  day  one  and  seven  after  exposure  to  hyperoxia
n the  hyperoxia  +  sodium  chloride  group,  and  decreased
igniﬁcantly on  day  14.  GSH  expression  in  the  hyperoxia  +
rythromycin groups  was  signiﬁcantly  enhanced  under  the
xposure to  hyperoxia  and  erythromycin  intervention  on  day
ne, seven  and  14,  but  showed  a  signiﬁcant  downward  trend
n day  14.  GSH  expression  detecting  by  BCA  conﬁrmed  the
LISA results.  After  exposure  to  hyperoxia  on  day  one  and
even, GSH  expression  was  signiﬁcantly  enhanced.  The  body
ay have  some  mechanism  for  self-protection  and  can  resist
yperoxic injury.  As  intracellular  ROS  increases,  the  sulfur
roups of  cysteine  in  GSH  have  a  strong  afﬁnity  activity,
nd can  be  used  as  electrophilic  targets  that  combine  with
OS. They  also  have  a  role  in  eliminating  ROS  and  lipid  per-
xidation, thus  avoiding  alveolar  cell  membrane  damage.
owever, exposure  to  hyperoxia  caused  GSH  protein  in  alve-
lar epithelial  cells  to  be  severely  damaged  by  oxidative
tress on  day  14,  and  GSH  expression  showed  no  signiﬁcant
eduction.
-glutamine-cysteine synthetase  is  the  rate-limiting
nzyme of  GSH  protein  synthesis,  which  regulates  intracel-
ular levels  of  GSH.21 The  present  study  demonstrated  that
he intervention  of  erythromycin  can  inhibit  up-regulation  of
CS protein  levels  in  lung  tissues  by  hyperoxia  exposure  on
ay one  and  seven  (p  <  0.05);  the  intervention  of  erythromy-
in had  no  obvious  inﬂuence  on  hyperoxia  exposure  on  day
4, but  -GCS  mRNA  expression  was  signiﬁcantly  enhanced
n day  seven  and  14  (p  <  0.05),  which  may  be  related  to  rel-
vant regulatory  proteins  after  -GCS  mRNA  transcription
ecause of  hyperoxia  exposure  damage,  resulting  in  eryth-
omycin inhibiting  the  up-regulation  of  GCS  protein  levels
y hyperoxia  exposure.
Infection and  inﬂammatory  reactions  are  key  factors
n the  pathogenesis  of  BPD  in  preterm  infants,  which  has
een conﬁrmed  by  animal  and  clinical  studies.22 It  has  been
eported that  IL-1  beta  as  a  proinfammatory  cytokine  has
 central  position  in  the  pathogenesis  of  BPD  and  has  an
mportant pathogenic  role  in  acute  and  chronic  lung  injury
n preterm  infants.23 In  the  present  study,  it  was  found  found
hat, compared  to  the  air  groups,  the  expression  of  IL-1  beta
n the  lung  tissue  of  premature  rats  of  hyperoxia  groups  was
igniﬁcantly increased  on  day  seven  and  reduced  on  day
4. Moreover,  compared  with  the  sodium  chloride  groups,
he expression  of  IL-1  beta  was  signiﬁcantly  reduced  in  the
rythromycin groups  on  day  one  and  seven.  By  contrast,  the
xpression of  GSH  in  the  lung  tissues  was  enhanced  after
he intervention  of  erythromycin  on  day  one,  seven,  and  14.
hese  results  demonstrated  that  the  primary  role  of  eryth-
omycin may  be  related  to  inhibiting  the  oxidative  burst
f neutrophils  and  the  release  of  inﬂammatory  mediators.
hus, one  of  the  main  mechanisms  of  MAs  in  treating  BPD
n the  preterm  infants  may  be  the  inhibition  of  neutrophil
xidative outbreak  and  the  release  of  inﬂammatory  media-
ors.
In summary,  erythromycin  can  inhibit  the  oxidative
utbreak of  neutral  granulocytes  in  lung  tissue,  improve
he antioxidant  role  of  GSH,  inhibit  the  release  of  the
nﬂammatory cytokine  IL-1  beta,  and  thus  has  an  impor-
ant role  in  reducing  oxidative  stress  in  the  development
1Cai  C  et  al.
f  hyperoxia-induced  lung  injury,  which  may  provide
 new  theoretical  basis  for  the  clinical  treatment  of
yperoxia-induced lung  injury.
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